Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS)

The scale uses a rational, structured and consistent approach to derive a relative ranking of the magnitude of clinically meaningful benefit that can be expected from anti-cancer treatments.

MCBS Scorecard Block

Score Cards

Access the ESMO-Scorecards by using the online filter, which allows you to filter either by Agent, Tumour or Score giving priority to different criteria such as Agent and Tumour Type and Tumour sub-type and Tumour sub-group in the Curative or Non-curative setting.

ESMO-MCBS

ESMO MCBS 1000x750

The scale uses a rational, structured and consistent approach to derive a relative ranking of the magnitude of clinically meaningful benefit that can be expected from anti-cancer treatments.

The ESMO-MCBS is an important first step to the critical public policy issue of value in cancer care, helping to frame the appropriate use of limited public and personal resources to deliver cost effective and affordable cancer care.

The ESMO-MCBS is a dynamic tool and its criteria are revised on a regular basis.

For more information on the scale check our factsheet and booklet!

Introducing the ESMO-MCBS

Fortunato Ciardiello, Elisabeth de Vries, Josep Tabernero and Alexandru Eniu introduce the ESMO-MCBS and its importance.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings